Innolight Technology (suzhou) Ltd.

Jiangsu Kanion Pharmaceutical Co., Ltd.

Newgen Therapeutics, Inc.

Jiangsu Kanion Parmaceutical Co. Ltd

Zhenzhong Wang

Wei Xiao

Yuzhou Sun

Xiangzhong Wang

Xigui Fang

Long Chen

Dengqun Yu

Chao Zhang

Donghan Wang

Meng Fang

Xiongfei Zhai

Chenfeng Zhang

Wang Shen

Hanfei Hu

Xiujuan Chang

Xiaodong Kang

Yongxiang Wang

Yun Wu

Enli Zhou

Haiying He

Jack Maung

Shuhui Chen

Xiaoling Zheng

Peng Li

Zhanwei Wang

Dongdong Yan

Bailing Yang

Aimin Zhang

Zongbin Li

Fei Hao

Zheng Kuan Wang

Xiaoyao Li

Zhangjian Huang

Baofeng Yang

Yonggan Zhang

Yihua Zhang

Jianbing Wu

Jiayi Zhu

Tuanjie Wang

Qingming Guo

Xu Li

Shasha Gu

Guiping Li

Haibo Li

Quanchang Zhang

Liang Cao

Wenjun Liu

Zhimin Du

Jiang Chang

Shuming Zhu

Yingguang Li

Zeyu Cao

Xin Li

Chaoqian Xu

Xueshi Huang

Yanjie Lv

Yunlong Bai

Jinhui Wang

Zhengkuan Wang

Ningbo Cheng

Kejin Zhu

Yong Zhang

Hui Zhang

Yanqiu Wang

Zheng Wang

An optical module package structure, comprising a housing, and a circuit board, a first device, and a sub-board that are packaged in the housing. The housing comprises a first housing and a second housing. An outer surface of the first housing is a main heat-dissipation surface. The first device is electrically connected to the circuit board by means of the sub-board. A first signal line is provided on the circuit board. An extension section is provided on the sub-board. The sub-board partially overlaps the circuit board, and is connected to same. The first signal line extends to the extension section. The surfaces of the sub-board and the circuit board which partially overlap each other face opposite directions. The first device is electrically connected to the extension section. The first device is provided with a heat-dissipation surface. The heat-dissipation surface faces the first housing, and is thermally connected to same.

Optical module package structure

The disclosure relates to a traditional Chinese medicine composition, comprising active ingredients derived fromoretartifactus and Lapis Chloriti, the said active ingredients comprise in parts by weight: at least 1600 parts of amino acids; at least 120 parts of gallic acid; at least 130 parts of liquiritin; at least 20 parts of liquiritigenin; at least 400 parts of baicalin; at least 40 parts of oroxyloside; at least 120 parts of wogonoside; at least 280 parts of glycyrrhizic acid; at least 12 parts of chrysin-7-O-β-D-glucoronic acid; at least 50 parts of aloe-emodin-8-O-β-D-glucopyranoside; at least 30 parts of chrysophanol-1-O-β-D-glucopyranoside; at least 45 parts of chrysophanol-8-O-β-D-glucopyranoside; at least 260 parts of hyodeoxycholic acid; at least 150 parts of cholic acid. The traditional Chinese medicine composition in the present invention possess antipyretic, anti-inflammatory and antitussive effects.

Traditional Chinese medicine composition and use thereof

The present disclosure discloses salts formed by 2-(1-acyloxy-n-pentyl)benzoic acid and basic amino acid or aminoguanidine, a preparation method thereof, pharmaceutical preparations containing these salts, and application thereof in preparation of drugs for preventing or treating ischemic cardiovascular and cerebrovascular diseases, resisting thrombosis and improving cardio-cerebral circulation disorders. The compound of the present disclosure has excellent water solubility, aqueous solution stability and pharmacokinetic properties, also has significant anti-platelet aggregation, anti-thrombosis, anti-cerebral ischemia and neuroprotective activity. The compound of the present disclosure has significantly better effects than those of (S)-butylphthalide and potassium (R/S)-2-(1-hydroxy-n-pentyl) benzoate (PHPB), has significantly lower acute toxicity to mice by intravenous injection than that of butylphthalide and PHPB, has a lower inhibition rate of the hERG potassium channel in CHO-hERG cells than that of (S)-butylphthalide, and has a negative result in Bacterial Reverse Mutation Test (Ames test).

Salts formed by 2-(1-acyloxy-n-pentyl) benzoic acid and basic amino acid or aminoguanidine, and preparation method and application thereof

An optical module includes a housing, and a main circuit board, an optical transmitting assembly, an optical receiving assembly, and an electrical connector that are disposed inside the housing. The optical transmitting assembly includes at least two sets of lasers, a transmitting-end optical assembly, and a transmitting-end optical fiber receptacle. The optical receiving assembly includes at least two sets of photoelectric detectors, a receiving-end optical assembly, and a receiving-end optical fiber receptacle. The electrical connector electrically connects the optical transmitting assembly and the optical receiving assembly to the main circuit board.

Optical module

A traditional Chinese medicine composition, made from cassia twig,alba, peach kernel in equal proportions. The traditional Chinese medicine composition comprises paeoniflorin, amygdalin, benzoylpaeoniflorin, cinnamic acid, paeonol, and cinnamaldehyde. The composition has the advantages of high production efficiency, high content of effective ingredients, high transfer rate ofacid, reduced hygroscopicity, and improved dissolution of index ingredients.

Traditional Chinese medicine composition and preparation method and application thereof

Aditerpene lactone composition is provided. The extract can lower the neurological function score of a cerebral ischemia-reperfusion rat, reduce the cerebral ischemia area and the water content after brain tissue edema, improve SOD activity, and decrease the MDA content. The composition can inhibit rabbit platelet aggregation induced by PAF and ADP inducers at different time points so as to reduce the maximum aggregation rate. In addition, experiments show that the effect of each monomer compound in thediterpene lactone composition is significantly increased at certain proportion.

Gingko diterpene lactone composition

Aditerpene lactone composition is provided. The composition has the effect of improving a depressive state. The composition can prolong a tail flick interval time and a swimming interval time of a mouse to different degrees and can also increase the frequency of escaping from electric shock to different degrees. The additional addition of a certain amount of ginkgolide C, ginkgolide J, and ginkgolide L greatly enhances the effect of improving the depressive state. It is further proved through experiments that after the provision of thediterpene lactone composition, indexes, such as SOD, MDA, GSH, and TAC, can be improved to different degrees. For example, after the addition of a certain amount of ginkgolide C, ginkgolide J, and ginkgolide L, the improving effect gets more obvious, the oxidative stress level can be better improved, and the oxidative damage can be relieved.

Ginkgo diterpene lactone composition

Disclosed in the present invention are an emodin succinyl ester compound, a preparation method therefor and a use thereof, the emodin succinyl ester compound having the structure as represented by formula I (R being a Calkyl group). The method provided in the present invention has a simple method course, and may effectively save time in synthesis and reduce costs, being simple to operate, being easy to implement, and being suitable for industrial production. Experiments show that the emodin succinyl ester compound of the present invention may better promote the healing of diabetic wounds than emodin, and may be used for preparing a drug for promoting the healing of diabetic wounds. Moreover, it has been confirmed by means of performing pharmacological experiments on rats suffering from experimentally mixed hyperlipidemia that the emodin succinyl ester compound of the present invention is superior to emodin, and has the advantages of having a remarkable blood fat lowering effect, being safe, being simple and convenient to administer, the raw materials being low cost and readily available, and being easy to transport and store.

Emodin succinyl ester compound, preparation method therefor and application thereof

A circuit board includes an upper surface, a lower surface, a first end surface connecting the upper surface and lower surface, and a heat dissipation block. The first end surface of the circuit board has an open slot, the open slot extending through the upper surface and lower surface, and the heat dissipation block being arranged inside the open slot. The heat dissipation block has a first surface, the first surface facing away from the lower surface of the circuit board and extending to the first end surface of the circuit board. The inside of the open slot has a stop structure, the stop structure preventing the heat dissipation block from moving toward the first end surface of the circuit board.

Circuit board and optical module having such circuit board

An optical modulator includes: a bottom substrate layer, having a first surface; a traveling-wave electrode, being disposed on the first surface of the bottom substrate layer and including a plurality of ground electrodes and a plurality of signal electrodes between the ground electrode; an optical waveguide disposed inside the bottom substrate layer; and a shield layer, including a substrate and a metal layer, the substrate covering at least a portion of the traveling-wave electrode and the metal layer being disposed on the surface of the substrate facing away from the traveling-wave electrode. Each of the ground electrodes is electrically connected to the metal layer to provide electromagnetic shielding for the signal electrodes between the ground electrodes.

Optical modulator

An optical module includes a housing, and a main circuit board, an optical transmitting assembly, an optical receiving assembly, and an electrical connector that are disposed inside the housing. Each one of the optical transmitting assembly and optical receiving assembly includes at least two sets of optoelectronic chips, an optical assembly, and an optical fiber receptacle. The electrical connector electrically connects the optical transmitting assembly and/or optical receiving assembly to the main circuit board.

A substrate packaging structure includes: a first substrate and a second substrate that are electrically connected; a plurality of conductive blocks arranged on each one of the first substrate and the second substrate, and electrically connected to each other; first and second conductive areas respectively formed on upper and side surfaces of the first substrate; a first reference conductive area formed below the upper surface of the first substrate and electrically connected to the first and second conductive areas; third and fourth conductive areas respectively formed on upper and side surfaces of the second substrate; and a second reference conductive area formed below the upper surface of the second substrate and electrically connected to the third and fourth conductive areas. The first conductive area on the first substrate is electrically connected to the third conductive area on the second substrate.

Substrate packaging structure including conductive blocks and conductive areas formed on substrates and optical module including same

The present invention discloses a salt form, crystal form and intermediate of the compound 1, and preparation method thereof. 

Salt form and crystal form of 1,2,5-thiadiazolidin-1,1-dioxide, preparation method thereof and intermediate

An optical module may include a case, an optical assembly, a circuit board interface positioned on the case, and a circuit board attached to the case through the circuit board interface. The optical assembly may be arranged in the case. The circuit board may include a first area that may electrically connect the circuit board to the optical assembly. The circuit board may also include a second area that may secure the circuit board to the circuit board interface. An optical module manufacturing method is also provided.

Optical module and manufacturing method thereof

Growing community of inventors

Jiangsu, China

Zhenzhong Wang